— Know what they know.
Not Investment Advice

ELEV NASDAQ

Elevation Oncology, Inc.
1W: +0.0% 1M: -3.6% 3M: +7.3% 1Y: -86.7% 3Y: -74.1%
$0.36
Last traded 2025-08-01 — delisted
NASDAQ · Healthcare · Biotechnology · $21.6M mcap · 44M float · 3.11% daily turnover · Short 29% of daily vol

Balance Sheet Trends

Total Assets
$96M +7.3% ▲
5Y CAGR: +118.6%
Total Liabilities
$36M +3.8% ▲
5Y CAGR: +35.5%
Shareholders Equity
$60M +9.5% ▲
Cash & Investments
$93M +12.1% ▲
5Y CAGR: +121.7%
Total Debt
$31M +3.3% ▲
Net Debt
-$18M +4.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$79M$146M$46M$49M$49M
Short-Term Investments$0$0$44M$34M$44M
Cash & ST Investments$79M$146M$90M$83M$93M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$3M$3M$5M$2M
Total Current Assets$81M$149M$93M$88M$95M
Property, Plant & Equip.$56K$38K$98K$59K$34K
Goodwill & Intangibles$56$38K$98$59$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$65K-$6K$1M$1M$866K
Total Non-Current Assets$121K$70K$1M$1M$900K
Total Assets$81M$149M$94M$89M$96M
— Liabilities —
Accounts Payable$6M$6M$6M$507K$559K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$2M$2M
Total Current Liabilities$7M$9M$16M$4M$4M
Long-Term Debt$0$0$29M$30M$31M
Other Non-Current Liab.$15K$8K$2K$0$0
Total Non-Current Liabilities$97M$8K$29M$30M$31M
Total Liabilities$104M$9M$45M$34M$36M
— Equity —
Common Stock$0$2K$2K$4K$6K
Retained Earnings-$23M-$55M-$150M-$196M-$240M
Accumulated OCI$0-$0-$161K$9K$61K
Total Stockholders Equity-$23M$141M$49M$55M$60M
Total Liabilities & Equity$81M$149M$94M$89M$96M
— Key Metrics —
Total Debt$0$0$29M$30M$31M
Net Debt-$79M-$146M-$16M-$19M-$18M
Total Investments$0$0$44M$34M$44M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms